Related Experiment Videos
Prognostic factor clustering in breast cancer: biology or chronology?
European Journal of Cancer (Oxford, England : 1990)
|January 1, 1995
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
BIRC5 (survivin): a pejorative prognostic marker in stage II/III breast cancer with no response to neoadjuvant chemotherapy.
Breast cancer research and treatment·2016
Outcome impact of PIK3CA mutations in HER2-positive breast cancer patients treated with trastuzumab.
British journal of cancer·2013
A nomogram to predict individual prognosis in node-negative breast carcinoma.
European journal of cancer (Oxford, England : 1990)·2012
Psychological distress and delusional memories after critical care: a literature review.
International nursing review·2010
Identification of biological factors predictive of response to imatinib mesylate in aggressive fibromatosis.
British journal of cancer·2010
Decluttering chemotherapy agents for HER2+early breast cancer: Do we still need carboplatin?
European journal of cancer (Oxford, England : 1990)·2026
Natural history and treatment outcomes in aggressive angiomyxoma: A single institution experience.
European journal of cancer (Oxford, England : 1990)·2026
Diagnostic pitfalls and unmet needs in neuroendocrine neoplasms: The added value of collegial expert pathology review through the national TENpath network.
European journal of cancer (Oxford, England : 1990)·2026
Twenty-five years survival of primary central nervous system lymphomas treated with the C5R regimen.
European journal of cancer (Oxford, England : 1990)·2026
Broad baseline-variable profiling of visceral conversion in bone-only HR+/HER2 - metastatic breast cancer treated with CDK4/6 inhibitors.
European journal of cancer (Oxford, England : 1990)·2026
Development of an age specific EORTC questionnaire to assess the health-related quality of life (HRQOL) of children with cancer aged 8-14 years - a mixed-methods content elicitation phase I & II EORTC QLG study.
European journal of cancer (Oxford, England : 1990)·2026
An integrative clinical-molecular model as an auxiliary predictive tool for glioma malignancy grade.
Neurological research·2026
Evaluating adenoma detection and miss rates in tandem colonoscopy: Limitations of surrogate quality indicators.
Advances in clinical and experimental medicine : official organ Wroclaw Medical University·2026
Predicting Radioiodine Therapy Response in Advanced and Recurrent Thyroid Cancer.
Endocrine-related cancer·2026
Refining risk stratification after indeterminate urinary cytology: Evidence from Bladder EpiCheck.
Cancer cytopathology·2026
PGR expression as a pharmacogenomic companion biomarker to GENE70-derived genomic risk in ER-positive/HER2-negative breast cancer.
Pakistan journal of pharmaceutical sciences·2026